Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Press/Media
Datasets
Activities
Fellowships, Honors, and Prizes
Search by expertise, name or affiliation
A tale of two receptors:Insulin and insulin-like growth factor signaling in cancer
Douglas Yee
Medicine - Hematology, Oncology, Transplant
Office of Academic Clinical Affairs
Cellular Mechanisms of Cancer
Research output
:
Contribution to journal
›
Article
›
peer-review
25
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'A tale of two receptors:Insulin and insulin-like growth factor signaling in cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Trial
100%
Phase I Trials
100%
Malignant Neoplasm
100%
Protein Tyrosine Kinase Inhibitor
100%
Insulin Receptor
100%
Somatomedin C Receptor
100%
Somatomedin
100%
Keyphrases
Insulin-like
100%
Growth Factor Signaling
100%
Insulin
100%
In Cancer
100%
Insulin-like Growth Factor 1 Receptor (IGF1R)
100%
Clinical Trials
33%
Phase I Trial
33%
Tyrosine Kinase Inhibitor
33%
Endocrine Changes
33%
Agent Types
33%
OSI-906
33%
Neuroscience
Somatomedin
100%
Insulin-Like Growth Factor 1 Receptor
100%
Tyrosine Kinase Inhibitor
100%
Insulin Receptor
100%